FDAFDA · Food and drugs·Recall number D-0166-2025
UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323
Published January 1, 2025 · Recall initiated: November 14, 2024
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product distributed by the firm is tainted.
What to do
Voluntary: Firm initiated · Press Release
Recall details
- Manufacturer
- MXBBB
- Distributor
- Product was sold via Amazon Marketplace.
- Lot
- Lot#: 24183, Exp 07/01/28
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.